Hyoscyamine (Levsin, Levbid, etc) is going off the market

All hyoscyamine products are unapproved. They came on the market before FDA approval was required. The FDA hasn't taken any action against these products...yet. But several companies have voluntarily withdrawn their products.

This has put a squeeze on the few remaining companies, creating a drug shortage.

There are only a handful of hyoscyamine products currently marketed. But these are either not available through some wholesalers and/or the cost of these may be prohibitive for some patients.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote